We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Checkpoint Proteins Miss Errors During Cell Replication

By Biotechdaily staff writers
Posted on 12 Jul 2006
Cancer researchers have identified a mechanism that may explain how some errors in cell replication go undetected by the "checkpoint” monitoring proteins, which may result in aneuploidy (cells with an abnormal number of chromosomes) and the generation of tumors.

Investigators at the Massachusetts Institute of Technology (Cambridge, USA) used small interfering RNA (RNAi) technology to evaluate the function of proteins associated with the binding of chromosome kinetochores to spindle microtubules during cell replication. More...
They found that RNAi-mediated depletion of the adenomatous polyposis coli (APC) protein and its binding partner, EB1, was unusual in affecting the movement and orientation of paired sister chromatids at the metaphase stage of cell division without apparently disturbing kinetochore-to-microtubule attachment. The result was misalignment of the chromatid pairs causing chromosome misaggregation and aneuploidy. The checkpoint proteins that normally monitor the binding of chromosomes to microtubules failed to detect this misalignment. These findings were published in the June 8, 2006, online edition of the EMBO (European Molecular Biology Organization) Journal.

"This is important because it is the first demonstration that interrupting the normal function of these proteins will cause the cell to become aneuploid,” said first author Dr. Viji Draviam, a research associate in the biology department of the Massachusetts Institute of Technology. "Our research sheds light on what could go wrong to cause an irregular number of chromosomes in cells even when the checkpoint proteins appear to be functioning properly.”



Related Links:
Massachusetts Institute of Technology

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.